RetinalGenix Technologies Inc.

APOLLO BEACH, FL · Founded 2017 · Medtech · Public

ophthalmic diagnostic imaging system for retinal disease detection and monitoring

Claim this profile

Follows are private to you and power your alerts

Updated · retinalgenixtechnologies.com

Sector
Medtech
Headquarters
APOLLO BEACH, FL
Founded
2017
Latest Form D
$4.7M, Feb 2024
Total capital
$4.7M
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$4.7M
2 Form D · last Feb 2024
33 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
0
3 pending

Capital timeline

2021202220232024FEDERAL ↑EQUITY ↓Cumulative $4.7M1st Form D$45K2nd Form D$4.7M
2021202220232024FEDERAL ↑EQUITY ↓Cumulative $4.7M1st Form D$45K2nd Form D$4.7M

Latest events

  • Private capital raisedForm D · SEC · 2nd filing$4.7M
  • Private capital raisedForm D · SEC · 1st filing$45K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Founders and team

From SEC Form D filings
  • Herbert GouldDirectorNamed in SEC Form D filings
  • Jerry KatzmanExecutive Officer, DirectorNamed in SEC Form D filings
  • Vinay MehindruDirectorNamed in SEC Form D filings
  • Virender AhluwaliaExecutive OfficerNamed in SEC Form D filings

What it has protected

USPTO · 0 granted of 3
  • PendingSustained Release Of Fenofibrate To Treat Age-related Macular Degeneration Or Diabetic RetinopathyUSPTOApplication PCTUS2024048541
  • PendingSustained Release Of Fenofibrate To Treat Age-related Macular Degeneration Or Diabetic RetinopathyUSPTOApplication 63642434
  • PendingSustained Release Of Fenofibrate To Treat Age-related Macular DegenerationUSPTOApplication 63585846

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .